Postural Recruitment Maneuver in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 Infection
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04475068 |
Recruitment Status :
Completed
First Posted : July 17, 2020
Last Update Posted : August 25, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Sars-CoV2 ARDS | Procedure: Lateral Position (left and right lateral decubitus) |
Study Type : | Observational |
Actual Enrollment : | 15 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Feasibility and Physiological Effects of a Postural Recruitment Maneuver in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 Infection |
Actual Study Start Date : | July 17, 2020 |
Actual Primary Completion Date : | September 30, 2020 |
Actual Study Completion Date : | October 31, 2020 |

Group/Cohort | Intervention/treatment |
---|---|
Moderate to severe ARDS patients due to COVID-19 infection
Mechanically ventilated patients with moderate to severe ARDS due to COVID-19 infection admitted to the COVID Intensive Care Unit of Rebagliati Hospital.
|
Procedure: Lateral Position (left and right lateral decubitus)
Prior to initiating the protocol, patients will be sedated deeply with sedatives and opioids and paralyzed. Patients will be evaluated in 5 positions sequentially: 1) Supine 2) Left lateral 3) Supine 4) Right lateral 5) Supine. The side with the least ventilation evaluated by EIT will define which side will start the sequence. Each step will last 30 minutes. Aeration measured by Electric Impedance Tomography (EIT) and lung ultrasound, distribution of the lung ventilation and perfusion measured by EIT, ventilator and hemodynamic parameters, esophageal pressure, and blood gas analysis will be recorded at the end of each step. Continuous monitoring of blood pressure, heart rate and saturation of arterial blood (SpO2) will be carried out during all steps of the protocol to assess the tolerance to the procedure. |
- Effects of a postural recruitment maneuver in lung aeration [ Time Frame: Through study completion (up to 24 hours) ]Lung aeration measured by ultrasound reaeration score, ranges from 0 (all regions are well aerated) to 36 (all regions are consolidated).
- Effects of a postural recruitment maneuver in distribution of ventilation [ Time Frame: Through study completion (up to 24 hours) ]Distribution of ventilation measured by EIT (distribution and changes in the impedance in AU, arbitray units)
- Effects of a postural recruitment maneuver in gas exchange [ Time Frame: Through study completion (up to 24 hours) ]Gas exchange measured by blood gas analysis (PaO2, PaCO2, in mmHg) and capnography (end-tidal CO2, in mmHg)
- Effects of a postural recruitment maneuver in respiratory mechanics [ Time Frame: Through study completion (up to 24 hours) ]Respiratory mechanics measured by esophageal balloon (esophageal pressure, transpulmonary pressure, in cmH2O)
- Effects of a postural recruitment maneuver in hemodynamic [ Time Frame: Through study completion (up to 24 hours) ]Hemodynamic data measured by invasive arterial monitoring (mean arterial pressure, in mmHg)
- Feasibility of a postural recruitment maneuver [ Time Frame: Through study completion (up to 24 hours) ]Oxigenatory tolerance evaluated with pulse oximeter (arterial oxygen saturation, in percentage)

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Patients > 18 years of age
- Patients with moderate-to-severe ARDS as per the Berlin definition
- Infection due to COVID-19
- Body mass index (BMI) ≤ 35 kg /m^2.
Exclusion Criteria:
-
Contraindication for EIT monitoring
- Unstable spine or pelvic fractures
- Pacemaker, automatic implantable cardioverter defibrillator
- Skin lesions between the 4th and 5th ribs where the EIT belt is worn
- Pregnancy
-
Major hemodynamic instability::
- Mean arterial pressure lower than 60 mm Hg despite adequate fluid resuscitation and use of vasopressors.
- FC> 120 or <60 per minute
- Presence of uncontrolled arrhythmias.
- More than 1 week of mechanical ventilation
- Failure of more than 2 extrapulmonary organs.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04475068
Peru | |
Hospital Rebagliati | |
Jesús María, Lima, Peru, Lima 11 |
Principal Investigator: | Rollin Roldán, MD | Hospital Nacional Edgardo Rebagliati Martins |
Responsible Party: | Rollin Roldán, Principal investigator, Hospital Nacional Edgardo Rebagliati Martins |
ClinicalTrials.gov Identifier: | NCT04475068 |
Other Study ID Numbers: |
HNEdgardoRebagliatiMartins |
First Posted: | July 17, 2020 Key Record Dates |
Last Update Posted: | August 25, 2021 |
Last Verified: | August 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Respiratory Distress Syndrome Respiratory Distress Syndrome, Newborn Acute Lung Injury Lung Diseases Respiratory Tract Diseases |
Respiration Disorders Infant, Premature, Diseases Infant, Newborn, Diseases Lung Injury |